Indian shares fell on Monday, weighed down by losses in pharmaceutical stocks, although shares of Pfizer Inc’s Indian arm jumped on positive data for the parent firm’s experimental pill against COVID-19. The blue chip NSE Nifty 50 index fell 0.30% to 17,863.05 and the benchmark S&P BSE Sensex fell 0.29%…
London: Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain. After five to six months, the effectiveness of the Pfizer jab at…
London: Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to study published in The Lancet journal. The researchers from University College London (UCL) in the UK noted that if the…
A Brazilian congressman who has denounced alleged wrongdoing in a 1.6 billion reais ($323 million) COVID-19 vaccine contract signed by Brazil’s government arrived at a Senate commission inquiry on Friday wearing a bullet-proof vest for safety. Congressman Luis Miranda and his brother Luis Ricardo Miranda,…
Coronavirus in India LIVE Updates: Digital companies with huge online presence such as Paytm, Makemytrip, Infosys and others are eyeing approval to start vaccine bookings on their platforms in third party integration with CoWIN. India has been ramping up vaccination to tackle the Covid-19 cases and has so far…
Recently, countries such as Saudi Arabia, the UAE, Bahrain and Philippines have expressed concerns over the approval granted to Chinese vaccines and their efficacy. China has developed two Covid-19 vaccines that have been approved by the World Health Organisation (WHO). These are Sinovac and Sinopharm. China has…